Skip to main content
. 2016 Dec 19;7:494. doi: 10.3389/fphar.2016.00494

Table 1.

Anti-Xa activity and rivaroxaban plasma concentrations.

Time after the lastrivaroxaban dose Anti-Xa activity (ng/ml) Rivaroxaban plasmaconcentrations (ng/ml)
24 h 231 not performed
48 h 110 88.3
60 h 81 not performed
72 h 66 70.5
84 h 66 not performed
96 h 34 35.6